Lipocine Inc.
LPCN | NASDAQ
$2.24
+$0.03 (+1.36%)
At close: Sep 21, 2026, 4:00 PM ET
$2.24
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 1.98M | 11.2M | -2.85M | 500K | 16.14M | n/a |
Cost of Revenue | 8.58M | n/a | 10.18M | 8.56M | 7.67M | n/a |
Gross Profit | -6.61M | 11.2M | -13.03M | -8.06M | 8.48M | n/a |
Operating Income | -10.37M | -1.16M | -17.93M | -12.12M | 3.15M | -18M |
Interest Income | 744.07K | 1.15M | 1.37M | 572.58K | 67.7K | 75.65K |
Pretax Income | -9.63M | 9.03K | -16.35M | -10.76M | -634.2K | -20.96M |
Net Income | -9.63M | 8.35K | -16.35M | -10.76M | -634.4K | -20.96M |
Selling & General & Admin | 3.76M | 5M | 4.9M | 4.06M | 5.33M | 8.25M |
Research & Development | n/a | 7.35M | n/a | n/a | n/a | 9.75M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.76M | 12.35M | 4.9M | 4.06M | 5.33M | 18M |
Interest Expense | n/a | n/a | n/a | 27.1K | 203.29K | 386.62K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 12.35M | 12.35M | 15.08M | 12.62M | 13M | 18M |
Income Tax Expense | 200 | 681 | 755 | 681 | 200 | 200 |
Shares Outstanding (Basic) | 5.45M | 5.34M | 5.27M | 4.99M | 3.3M | 3.25M |
Shares Outstanding (Diluted) | 5.71M | 5.42M | 5.27M | 5.26M | 5.15M | 3.28M |
EPS (Basic) | -1.77 | 0 | -3.14 | -2.15 | -0.19 | -6.46 |
EPS (Diluted) | -1.69 | 0 | -3.14 | -2.05 | -0.12 | -6.40 |
EBITDA | -9.57M | 50.14K | -16.32M | -10.72M | -430.53K | -17.99M |
EBIT | -9.63M | 9.03K | -16.35M | -10.73M | -430.91K | -18M |
Depreciation & Amortization | 60.78K | 41.11K | 28.66K | 9.45K | 380 | 3.55K |
Add to Watchlist
Select watchlists to add or remove LPCN